Once for Life

Once for Life

Creating transformational gene therapies and peptide infusions that treat the most prevalent diseases to restore health and renew life


Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive, one-time treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site

 

Latest News:  Feb. 21, 2017: Press release | U.S. PATENT FOR UROCORTIN 2 GENE CONSTRUCTS ISSUED

  Feb. 7, 2017: FierceBiotech | Renova takes over Janssen's rights to heart failure candidate stresscopin

View All News
Subscribe to receive company press releases and announcements
*required